Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints

药效学 药代动力学 美罗培南 加药 医学 肾功能 药理学 人口 内科学 胃肠病学 泌尿科 抗生素 微生物学 生物 抗生素耐药性 环境卫生
作者
Sujata M. Bhavnani,Michael Trang,David C. Griffith,Olga Lomovskaya,Jeffrey Hammel,J. Loutit,Sue Cammarata,Michael N. Dudley,Paul G. Ambrose,Christopher M. Rubino
出处
期刊:Antimicrobial Agents and Chemotherapy [American Society for Microbiology]
卷期号:66 (12) 被引量:6
标识
DOI:10.1128/aac.02130-21
摘要

Meropenem-vaborbactam is a fixed-dose beta-lactam/beta-lactamase inhibitor with potent in vitro and in vivo activity against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales. Pharmacokinetic-pharmacodynamic (PK-PD) target attainment analyses were undertaken using population pharmacokinetic models, nonclinical PK-PD targets for efficacy, in vitro surveillance data, and simulation to provide support for 2 g meropenem-2 g vaborbactam every 8 h (q8h) administered as a 3-h intravenous (i.v.) infusion, and dosing regimens adjusted for patients with renal impairment. Simulated patients varying by renal function measure (estimated glomerular filtration rate [eGFR], mL/min/1.73 m2 and absolute eGFR, mL/min) and resembling the clinical trial population (complicated urinary tract infection, including acute pyelonephritis) were generated. The PK-PD targets for meropenem, the percentage of time on day 1 that free-drug plasma concentrations were above the MIC (%T>MIC), and vaborbactam, the ratio of free-drug plasma area under the concentration-time curve (AUC) on day 1 to the MIC (AUC:MIC ratio), were calculated. Percent probabilities of achieving meropenem free-drug plasma %T>MIC and vaborbactam free-drug plasma AUC:MIC ratio targets were assessed. MIC distributions for Enterobacterales, KPC-producing Enterobacterales, and Pseudomonas aeruginosa were considered as part of an algorithm to assess PK-PD target attainment. For assessments of free-drug plasma PK-PD targets associated with a 1-log10 CFU reduction from baseline, percent probabilities of PK-PD target attainment ranged from 81.3 to 100% at meropenem-vaborbactam MIC values of 4 or 8 μg/mL among simulated patients. The results of these PK-PD target attainment analyses provide support for a dosing regimen of 2 g meropenem-2 g vaborbactam q8h administered as a 3-h i.v. infusion, with dosing regimens adjusted for patients with renal impairment and a meropenem-vaborbactam susceptibility breakpoint of ≤8 μg/mL (tested with a fixed vaborbactam concentration of 8 μg/mL) for Enterobacterales and P. aeruginosa based on these dosing regimens.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sh33发布了新的文献求助10
刚刚
ANDRT完成签到,获得积分10
刚刚
刘航完成签到,获得积分10
刚刚
所所应助墨尔根戴青采纳,获得10
刚刚
神的女人完成签到,获得积分10
1秒前
1秒前
1秒前
江哥发布了新的文献求助10
2秒前
小马甲应助能干的鞅采纳,获得10
2秒前
能量球完成签到,获得积分10
2秒前
苹果酸奶完成签到 ,获得积分10
3秒前
复照完成签到,获得积分10
4秒前
可可应助QWE采纳,获得10
4秒前
ztl17523发布了新的文献求助10
5秒前
非言墨语完成签到,获得积分10
5秒前
乔垣结衣发布了新的文献求助10
6秒前
yar应助将将采纳,获得10
6秒前
在水一方应助开朗的觅柔采纳,获得10
7秒前
月亮邮递员完成签到 ,获得积分10
7秒前
7秒前
7秒前
CT完成签到,获得积分10
7秒前
8秒前
8秒前
白樱恋曲完成签到 ,获得积分10
8秒前
8秒前
8秒前
开心人达发布了新的文献求助10
8秒前
Tammy完成签到 ,获得积分10
9秒前
Sun_Chen完成签到,获得积分10
9秒前
guyu完成签到,获得积分10
10秒前
ZK999完成签到,获得积分10
10秒前
青衣北风发布了新的文献求助10
11秒前
yyy完成签到 ,获得积分10
11秒前
夜曦完成签到 ,获得积分10
12秒前
13秒前
tao完成签到 ,获得积分10
13秒前
13秒前
玉玉发布了新的文献求助10
14秒前
Yoo.发布了新的文献求助10
14秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968771
求助须知:如何正确求助?哪些是违规求助? 3513646
关于积分的说明 11169065
捐赠科研通 3249011
什么是DOI,文献DOI怎么找? 1794589
邀请新用户注册赠送积分活动 875236
科研通“疑难数据库(出版商)”最低求助积分说明 804740